Today: 17 May 2026
Palantir stock slips in premarket as 2026 opens, even after Wedbush keeps $230 target
2 January 2026
1 min read

Palantir stock slips in premarket as 2026 opens, even after Wedbush keeps $230 target

NEW YORK, January 2, 2026, 04:55 ET — Premarket

  • Palantir Technologies shares fell 1.7% in premarket trading to $177.75.
  • Wedbush analyst Dan Ives reiterated a $230 price target, pointing to strong demand for the company’s AI platform.
  • Traders are watching a packed early-January macro calendar and an unconfirmed early-February earnings window.

Palantir Technologies Inc (PLTR.O) shares fell 1.7% to $177.75 in premarket trading on Friday. Premarket is trading before the 9:30 a.m. ET opening bell, when liquidity can be thinner.

The move came as a new year opened with a firmer tone across broader markets, with S&P 500 futures up 0.6% and Nasdaq futures up 1% as investors weighed whether the AI-led rally of 2025 can hold up to policy and data shocks. Traders have priced in a 15% chance of a U.S. rate cut this month and expect two more cuts this year, while a backlog of U.S. economic releases delayed by the government shutdown is due soon and could reset those bets.

That backdrop matters for Palantir because high-growth software stocks tend to move sharply when interest-rate expectations shift. Investors start 2026 trying to separate durable AI revenue growth from momentum trades that were fueled by easy money and fear of missing out.

A bullish sell-side call also landed late this week. Wedbush Securities analyst Dan Ives reiterated a $230 price target for Palantir in a note spotlighting five AI-focused names for 2026, and wrote: “Demand for Palantir’s Artificial Intelligence Platform remains ‘unprecedented’.” Business Insider

On the charts, Palantir is sitting below its 50-day moving average — a technical indicator that smooths the last 50 closing prices to track short-term trend — at about $181. The stock’s 200-day moving average, a longer-term trend gauge, stood near $168.89, while the company’s market value was about $424 billion, MarketBeat data showed.

For technical-focused investors, reclaiming the 50-day line can signal stabilizing momentum. Slipping toward — or through — the 200-day average often draws in sellers who use trend signals to manage risk.

Macro headlines are also back in the driver’s seat. A U.S. jobs report is due on January 9, commodity indexes are set to rebalance starting January 8, and OPEC+ meets on Sunday, while policy risks include a pending U.S. Supreme Court tariff ruling and an expected announcement of a new Federal Reserve chair, Reuters’ weekly “Take Five” noted. Reuters

The next company-specific catalyst is earnings. Wall Street Horizon currently lists Palantir’s next report as unconfirmed for February 2 after the close, based on its forecast methodology and the company’s historical cadence.

When that date is confirmed, investors will look for any change in guidance and for evidence that demand for Palantir’s AI software is translating into sustained revenue growth and margins. The tone around government versus commercial momentum will likely matter as much as the headline numbers.

Stock Market Today

  • Understanding Tax-Loss Harvesting Amid Stock Market Gains
    May 16, 2026, 7:47 PM EDT. Tax-loss harvesting is gaining traction as the stock market surges, offering investors a strategy to offset capital gains by selling investments at a loss. This technique can reduce taxable income and boost after-tax returns. Wall Street professionals are increasingly adopting this approach to optimize portfolios in a high-gain environment. The method involves careful timing and selection of assets to comply with tax regulations while maintaining market positions. As tax considerations grow in importance, investors seek effective strategies like tax-loss harvesting to manage their liabilities amidst fluctuating markets.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Tesla stock today: TSLA watched ahead of quarterly delivery report after Musk gift filing
Previous Story

Tesla stock today: TSLA watched ahead of quarterly delivery report after Musk gift filing

SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus
Next Story

SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus

Go toTop